Agilent, ISB to Collaborate on Multiple Reaction Monitoring Atlas

NEW YORK (GenomeWeb News) – Agilent Technologies and the Institute for Systems Biology announced today that they will collaborate in developing the Human Multiple Reaction Monitoring Atlas, a resource designed to enable scientists to perform quantitative analysis of all human proteins.

The collaboration is supported by a $4.6 million National Human Genome Research Institute grant to ISB Director of Proteomics Robert Moritz and ISB President Lee Hood as part of the American Recovery and Reinvestment Act. Also participating in the project is Ruedi Aebersold of the Swiss Federal Institute of Technology (ETH), with additional funding coming from the European Research Council.

The project, to be conducted over two years, will use Agilent's triple quadrupole and quadrupole time-of-flight liquid chromatography/mass spectrometry systems and nanoflow HPLC-Chip/MS systems at ISB in Seattle and at ETH in Zurich.

"We believe this will be a revolutionary development in protein analysis," said ISB's Moritz in a statement, "one that will accelerate and catalyze the routine use of protein quantitation for immensely important breakthroughs in the understanding, early detection and monitoring of human disease."